Here is something I never expected to write: your sex chromosomes are doing far more inside your cells than deciding your biological sex. A major new review in the journal Science, published 1 October 2026, gathers years of human studies, mouse models and genomic research and reaches a striking conclusion: genes on the X and Y chromosomes shape how we age, how our immune system behaves, and how we develop cancer and heart disease, often independently of estrogen and testosterone.
Like most doctors of my generation, I was taught that health differences between men and women come down mostly to hormones. The review’s authors, Dr. Dan Theodorescu of the University of Arizona Cancer Center and Dr. Dena B. Dubal of UCSF, argue that sex chromosomes deserve a seat at that table. Hormones matter enormously, but the chromosomes themselves are active players.
“X and Y chromosomes are often thought of as simple determinants for biological sex, but their role in human health is much larger. Our review shows that these chromosomes carry genetic instructions that shape how our cells age and how our bodies defend against major diseases throughout our lives.” – Dr. Dan Theodorescu
How sex chromosomes shape cancer, immunity and heart disease
The X chromosome carries around 1,500 genes, roughly five percent of the human genome. In women, one of the two X chromosomes is largely switched off early in development, but the silencing is leaky: 15 to 30 percent of genes on the “off” X keep working, and some switch back on with age. Female cells can therefore carry extra gene doses, which appear to influence how we age and get sick: a clear example of sex chromosomes working at the level of individual genes.
The Y chromosome story is stranger still. Despite its small gene count, the Y carries genes that regulate chromatin, immune signaling and transcription far beyond its role in male development. With age, some cells lose it: mosaic loss of the Y, measured in blood, is the most common somatic chromosomal change in aging men, becoming common by the seventh decade. It is associated with higher rates of cancer, heart disease, severe infections and Alzheimer’s disease, and smoking is its strongest known, partly reversible risk factor.
The most clinically exciting finding concerns cancer treatment. Tumors that lose the Y chromosome can evade the immune system, yet may respond better to immunotherapy. As Theodorescu explains: “Our laboratory has found that tumors that lose the Y chromosome can evade the immune system, yet may respond better to immunotherapy. Understanding this biology could help us tailor treatment.”
The takeaways, in plain language
- Sex chromosomes influence immunity, metabolism, brain aging, cancer and heart disease, not just reproductive biology.
- In women, loss of an X chromosome in blood cells rises with age, affecting over 35 percent of white blood cells after age 80, and is linked to higher leukemia risk.
- The authors call for clinical trials designed to be “sex-aware”, so treatments and diagnostics can be matched to each patient’s unique profile.
Why this should matter to new doctors like me
This is exactly the kind of finding that makes me glad I write about medical education: the science under our feet keeps moving. If sex chromosomes shape disease risk and treatment response, next decade’s medicine will have to be sex-aware in a way today’s guidelines are not. For those of us still building our clinical reflexes, it means asking sharper questions of every trial we read: was the result stratified by sex, and could chromosome-level differences explain what we are seeing?
It is also a reminder that graduation is the beginning of learning, not the end, something I keep returning to in my reflections on my first year as a doctor. And as medicine changes this fast, it is no surprise it keeps attracting people willing to start over, as I wrote recently about what career changers bring to our wards.
Read the fine print before rewriting the textbooks
A quick reality check from your junior doctor. This is a review paper, not a new clinical trial: it synthesizes existing evidence, and much of the mechanistic detail comes from mouse models. Turning chromosome biology into real tests and treatments will take years of careful human research. You can read the original review in Science (Dubal et al, DOI: 10.1126/science.aeh0145) if you want the full technical picture. Promising, but not practice-changing yet.
Frequently asked questions
Does this mean sex hormones don’t matter for health?
No. Hormones still drive a huge share of health differences between men and women. They are not the whole story: chromosome genes act both independently and alongside hormones.
Will doctors soon test my chromosomes to predict disease?
Not yet. Y-chromosome loss in blood is being explored as a biomarker and possible early warning sign, but it is not a clinical test today. The nearer change is sex-aware clinical trial design, so treatments can be personalized more precisely.
Is this settled science?
No. It is a fast-moving field built largely on animal and observational evidence so far, and the review itself calls for more investigation before any clinical translation. Treat it as a direction of travel, not a destination.
Written by Dr. Haiqa Afzal (MBBS). I am a newly qualified doctor writing about medical education and the science that will shape our wards. This article is for education, not medical advice.